pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Sarepta Therapeutics, Inc. ($SRPT) · news · pharmadog
← back to Sarepta Therapeutics, Inc.
News mentioning $SRPT
8
stories
3d
Sarepta could be ‘potential turnaround story’ with catalysts lined up into 2027
biospace
Aug 11, 26
Epicrispr lands $90M to advance epigenetic editing drug for rare muscle disease
biopharma dive
Jul 29, 26
Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, more
biospace
Jul 27, 26
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
biospace
Jul 27, 26
STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
stat
Jul 13, 26
Building a workforce engine for biomanufacturing
fiercebiotech
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
May 7, 26
STAT+: Next-gen Duchenne drug from Entrada disappoints
stat
